(AMS) American Shared Hospital - Ratings and Ratios

American Shared Hospital Services (NYSE MKT: AMS) specializes in providing advanced radiation therapy solutions, operating through two segments: Medical Equipment Leasing and Retail. The company offers equipment for Gamma Knife stereotactic radiosurgery, a precise treatment for brain tumors, arteriovenous malformations, and trigeminal neuralgia, using Leksell Gamma Knife units manufactured by Elekta. AMS also provides proton beam radiation therapy services in Orlando and Long Beach, which is notable for its precision and reduced side effects. They lease medical equipment and offer comprehensive support services, including planning, installation, reimbursement, and marketing, primarily to cancer treatment centers and hospitals worldwide. Founded in 1980, AMS is headquartered in San Francisco.

Based on technical and fundamental analysis, AMSs stock is expected to face headwinds in the next three months. The stock price is below its SMA20, SMA50, and SMA200, indicating a bearish trend. However, the low ATR of $0.09 suggests minimal volatility. Fundamentally, the low P/E ratio of 4.80 and P/B ratio of 0.71 may attract value investors, potentially leading to a rebound. The positive RoE of 14.87% indicates profitability, offering a favorable outlook despite technical challenges.